Publications by authors named "Yunchao Huang"

Background: Chronic empyema after total pneumonectomy is a potentially fatal complication.The aim of the study is to explore the treatment strategy and clinical efficacy of chronic empyema after pneumonectomy.

Methods: A retrospective analysis of 6 patients with chronic empyema after pneumonectomy in our hospital.

View Article and Find Full Text PDF

Background: Esophageal squamous cell carcinoma (ESCC) is a prevalent and aggressive gastrointestinal tumor, particularly in East Asia. However, there is a lack of consensus on the long-term survival outcomes of intrathoracic anastomosis and cervical anastomosis following esophagectomy. This study aims to provide a comprehensive summary of the long-term survival outcomes of these two anastomosis techniques.

View Article and Find Full Text PDF
Article Synopsis
  • A phase 3 study showed that combining camrelizumab with chemotherapy significantly improved progression-free survival in patients with advanced non-squamous non-small-cell lung cancer compared to chemotherapy alone.
  • After 5 years, overall survival rates were 31.2% for those receiving camrelizumab and chemotherapy versus 19.3% for those on chemotherapy alone, indicating a substantial benefit.
  • Patients who completed two years of treatment with camrelizumab had an impressive 5-year overall survival rate of 84.3%, reinforcing its effectiveness and safety as a first-line therapy for this cancer type.
View Article and Find Full Text PDF

Background: Serum neuron-specific enolase (NSE) had been associated with survival of several cancers. However, its prognostic significance for colorectal cancer (CRC) has not been effectively discussed. We aimed to investigate the relationship between baseline serum NSE and the overall survival (OS) of colorectal adenocarcinoma (CRAD) patients.

View Article and Find Full Text PDF
Article Synopsis
  • The article with the DOI 10.21037/tcr-20-2450 has been officially retracted.
  • This means the content of the article is no longer considered valid or reliable in the academic community.
  • Retracting an article typically occurs due to issues like ethical concerns, inaccuracies, or lack of compliance with research standards.
View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed the effectiveness of befotertinib, a drug for treating non-small cell lung cancer with EGFR T790M mutation, showing positive outcomes in patients with brain metastases and a manageable safety profile.
  • Two groups of patients received different doses of the drug, and after tracking their progress for nearly four years, the overall survival rates were reported as 23.9 months and 31.5 months for the lower and higher doses, respectively.
  • The results suggest that befotertinib offers significant overall survival benefits compared to other third-generation treatments, with adverse effects mostly manageable and in line with previous findings for similar cancer types.
View Article and Find Full Text PDF

The regulation of the cell cycle is essential for maintaining normal cellular function, especially in the development of diseases such as lung cancer. The cell cycle consists of four major phases (G1, S, G2 and M phases), which are characterized by a series of precise molecular events to ensure proper cell proliferation and division. In lung cancer cells, cell cycle dysregulation can lead to disordered proliferation and increased invasiveness of cancer cells.

View Article and Find Full Text PDF
Article Synopsis
  • A phase 2 trial tested neoadjuvant SHR-1701, with or without chemotherapy, in patients with unresectable stage III non-small-cell lung cancer (NSCLC), showing promising results.
  • The treatment achieved a post-induction objective response rate of 58% and an 18-month event-free survival rate of 56.6%, with surgical patients showing even better outcomes.
  • Overall, 25% of patients underwent successful surgery, indicating that neoadjuvant therapy could enable surgical intervention for patients who initially had unresectable tumors.
View Article and Find Full Text PDF

We report a patient with fever and cough for 2 months who was finally given a diagnosis of alveolar-pleural fistula due to aspergillus empyema. We successfully closed the alveolar-pleural fistula with a ventricular septal defect occluder through bronchoscopy. Endoscopic closure of an alveolar-pleural fistula with ventricular septal defect occluder is worth being explored.

View Article and Find Full Text PDF

Invasion and migration are the primary factors for mortality in lung adenocarcinoma (LUAD) patients. The precise role of RNA-binding motif protein15 (RBM15)-mediated m6A modification in LUAD is not yet fully clarified. This research aims to elucidate the mechanism of RBM15 in the invasion and migration of LUAD.

View Article and Find Full Text PDF

At present, diabetes mellitus (DM) has been one of the most endangering healthy diseases. Current therapies contain controlling high blood sugar, reducing risk factors like obesity, hypertension, and so on; however, DM patients inevitably and eventually progress into different types of diabetes complications, resulting in poor quality of life. Unfortunately, the clear etiology and pathogenesis of diabetes complications have not been elucidated owing to intricate whole-body systems.

View Article and Find Full Text PDF

Background: Peripheral T-cell lymphoma (PTCL) is a subtype of non-Hodgkin's lymphoma that occurs primarily at extranodal sites and is commonly treated using chemotherapy and radiotherapy. PTCL is more malignant than other lymphoid tumors, resulting in a poor prognosis.The 5-year recurrence rate remains high, and there is a lack of standard treatment for patients with relapse-resistant disease.

View Article and Find Full Text PDF

Background: The morbidity and mortality rates of esophageal squamous cell carcinoma (ESCC) are high in China. The overall survival (OS) of patients with ESCC is related to lymph node (LN) metastasis (LNM). This study aimed to discuss the impact of metastasis in LN stations on the OS of patients with pathologic N1 (pN1) ESCC.

View Article and Find Full Text PDF

Non-small-cell lung cancer (NSCLC) stands as a prevalent subtype of lung cancer, with circular RNAs emerging as key players in cancer development. This study elucidates the role of circRNA-CPA4 in NSCLC. Elevated circRNA-CPA4 expression in NSCLC lines was confirmed through qRT-PCR.

View Article and Find Full Text PDF
Article Synopsis
  • Adjuvant and neoadjuvant immunotherapy has been shown to enhance outcomes for patients with early-stage non-small cell lung cancer (NSCLC), but the best combination with chemotherapy is still unclear.!
  • The study's aim was to evaluate if adding toripalimab, an immunotherapy drug, to standard platinum-based chemotherapy improves event-free survival and major pathological responses in patients with stage II or III resectable NSCLC compared to chemotherapy alone.!
  • Conducted across 50 hospitals in China, the trial involved 501 patients, mostly with stage III NSCLC, and assessed outcomes like event-free survival and response rates over an interim analysis period ending November 2022.
View Article and Find Full Text PDF

Lung cancer is a prevalent malignancy, and fatalities of the disease exceed 400,000 cases worldwide. Lung squamous cell carcinoma (LUSC) has been recognized as the most common pathological form of lung cancer. The comprehensive understanding of molecular features related to LUSC progression has great significance in LUSC prognosis assessment and clinical management.

View Article and Find Full Text PDF